Abstract
The National Cancer Institute (NCI) Perspectives this year presented information on the systemic targeted radionuclide therapy (STaRT) research projects: (1) being investigated at the NCI's Intramural Center for Cancer Research; (2) funded by NCI's Radiation Research Program and other extramural programs; and (3) the appropriate National Institutes of Health/NCI funding mechanisms applicable to researchers for obtaining funds for STaRT projects.
Publication types
-
Research Support, N.I.H., Intramural
-
Review
MeSH terms
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Biomedical Research
-
Humans
-
Immunotoxins / therapeutic use
-
National Institutes of Health (U.S.)*
-
Neoplasms / radiotherapy*
-
Radioimmunotherapy / economics*
-
Recombinant Proteins / therapeutic use
-
Research Support as Topic*
-
Trastuzumab
-
United States
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Immunotoxins
-
Recombinant Proteins
-
Trastuzumab